CytoSorbents, Aferetica Launch Organ Perfusion System In Italy

CytoSorbents Corporation CTSO and Aferetica srl (Italy) have launched products to remove inflammatory mediators at Italy's European Society of Organ Transplantation Congress.
Aferetica's PerLife ex vivo organ perfusion system and CytoSorbents' PerSorb adsorber are based on the CytoSorbents ECOS-300CY sorbent technology.
PerLife is a system for an organ transplant that provides both perfusion and purification of the kidney and the liver, following organ retrieval and before organ implantation.
CytoSorbents' PerSorb perfusion cartridge is used to remove inflammatory mediators that can compromise the health and quality of the organs.
Related: CytoSorbents' Antithrombotic Removal System Scores Second FDA Breakthrough Device Tag
Price Action: CTSO shares are up 4.08% at $9.44 during the market session on the last check Monday.

Momentum41.85

Growth16.13

QualityN/A

Value60.77

Short

Medium

Long